Addus HomeCare Overview
Addus HomeCare Target Price
Analysts' average 12-month price target for Addus HomeCare is $110.
Get informed when a big investor buys or sells
+ FollowShare Price
$117.33
Average Target Price
$107.33
8.5% downside
8.5% downside3 analysts in the last 4 months
High: $134 | Low: $92
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | RBC Capital | $134 |  14.2% upside |  |
| 2026-07-08 | BarclaysAndrew Mok | $96 | 18.2% downside | |
| 2026-05-15 | Barclays | $92 | 21.6% downside | |
| 2026-02-25 | RBC CapitalBen Hendrix | $139 | 18.5% upside | |
| 2026-02-24 | Barclays | $112 | 4.5% downside | |
| 2026-01-07 | Truist FinancialClarke Murphy | $135 | 15.1% upside | |
| 2025-11-04 | BarclaysAndrew Mok | $117 | 0.3% downside | |
| 2025-09-02 | UBS | $145 | 23.6% upside | |
| 2024-12-16 | JMP SecuritiesConstantine Davides | $150 | 27.8% upside | |
| 2024-11-06 | StephensScott Fidel | $145 | 23.6% upside | |
| 2024-10-10 | KeyBancMatthew Gillmor | $150 | 27.8% upside | |
| 2024-09-23 | OppenheimerMichael Wiederhorn | $145 | 23.6% upside | |
| 2024-08-08 | RBC CapitalFrank Morgan | $141 | 20.2% upside | |
| 2024-08-07 | OppenheimerMichael Wiederhorn | $140 | 19.3% upside | |
| 2024-06-07 | OppenheimerMichael Wiederhorn | $130 | 10.8% upside | |
| 2024-05-31 | StephensScott Fidel | $128 | 9.1% upside | |
| 2024-05-28 | RBC CapitalFrank Morgan | $129 | 9.9% upside | |
| 2024-04-23 | BarclaysAndrew Mok | $83 | 29.3% downside | |
| 2024-04-01 | StephensScott Fidel | $115 | 2% downside | |
| 2022-06-29 | StephensScott Fidel | $101 | 13.9% downside | |
| 2022-05-04 | RBC Capital | $111 | 5.4% downside | |